Poseida Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for PBCMA-101

Created:

November 5, 2018

News organization:

First Word Pharma

Link to news item:

https://www.firstwordpharma.com/node/1602226?tsid=28&region_id=3

News type:

CIRM in the news